Difference between revisions of "Part:BBa K4165124"
Omnia Alaa11 (Talk | contribs) |
Omnia Alaa11 (Talk | contribs) |
||
Line 17: | Line 17: | ||
Got score of 4 out of 6 in our Quality assessment code after modeling by AlphaFold2.0. | Got score of 4 out of 6 in our Quality assessment code after modeling by AlphaFold2.0. | ||
− | + | <html> | |
<style> | <style> | ||
table, th, td { | table, th, td { |
Revision as of 17:41, 11 October 2022
HTRA Binding Peptide 30
part encodes for a synthetic peptide that binds to the PDZ domain of HTRA1 protein
Usage and Biology
A reversed sequence of a high affinity binding peptide is proposed for binding to the PDZ domain of HTRA1.
We were motivated by our chosen Tau binding peptide since it was the inverted sequence of a high affinity peptide that shown better affinity, so we decided to try it with our HTRA1 BP. Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
Got score of 4 out of 6 in our Quality assessment code after modeling by AlphaFold2.0.
cbeta_deviations | clashscore | molprobity | ramachandran_favored | ramachandran_outliers | Qmean_4 | Qmean_6 |
---|---|---|---|---|---|---|
0 | 16 | 3.73 | 20 | 60 | -5.832 | -3.92999 |
Dry Lab
Modeling
Figure 1.: 3D Model of H2D peptide Modelled by AlphaFold2.0 displayed in Pymol.
References
Dammers, C., Yolcu, D., Kukuk, L., Willbold, D., Pickhardt, M., Mandelkow, E., ... & Funke, S. A. (2016). Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease. PLoS One, 11(12), e0167432.